Clinical and Experimental Dermatology

Article	Citations
Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings	115
Two cases of COVID‐19 presenting with a clinical picture resembling chilblains: first report from the Middle East	100
Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital	88
Treatment options for leishmaniasis	57
Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice	56
COVID‐19 vaccine‐induced Stevens–Johnson syndrome	55
Skin manifestations of COVID‐19 in children: Part 1	52
WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID‐19): from bedside to phone‐side	52
Reduction in skin cancer diagnoses in the UK during the COVID‐19 pandemic	46
A cutoff value for the Systemic Immune‐Inflammation Index in determining activity of Behçet disease	42
Potential use of turmeric in COVID‐19	42
Irritant contact dermatitis in healthcare workers as a result of the COVID‐19 pandemic: a cross‐sectional study	41
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID‐19 vaccine	39
De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine	38
Line‐field optical coherence tomography: in vivo diagnosis of basal cell carcinoma subtypes compared with histopathology	38
Janus kinase inhibitors for atopic dermatitis: a promising treatment modality	38
COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers	38
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination	37
Skin manifestations of COVID‐19 in children: Part 2	36
Facial dermatoses in the general population due to wearing of personal protective masks during the COVID‐19 pandemic: first observations after lockdown	34
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’	34
Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance	34
Line‐field confocal optical coherence tomography for actinic keratosis and squamous cell carcinoma: a descriptive study	33
Performance of ChatGPT on Specialty Certificate Examination in Dermatology multiple-choice questions	33
The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience	32

Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic	31
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns	31
Chilblain‐like lesions: a case series of 41 patients during the COVID‐19 pandemic	29
Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?	29
A flare of pre‐existing erythema multiforme following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine	29
Successful treatment with dupilumab of an adult with Netherton syndrome	29
Novel targets and therapies for keloid	28
Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics	28
Reactive infectious mucocutaneous eruption: Mycoplasma pneumoniae ‐induced rash and mucositis and other parainfectious eruptions	27
Associations of particulate matter with atopic dermatitis and chronic inflammatory skin diseases in South Korea	25
Anifrolumab for treatment of refractory cutaneous lupus erythematosus	24
Clinical characteristics and disease burden in prurigo nodularis	24
Skin manifestations of COVID‐19 in children: Part 3	24
Management of nail psoriasis	24
Merkel cell carcinoma	23
Vitiligo: an update on systemic treatments	23
Pityriasis rubra pilaris‐like eruption following administration of the BNT163b2 (Pfizer–BioNTech) mRNA COVID‐19 vaccine	23
Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature	23
Skin signs resembling vascular acrosyndromes during the COVID‐19 outbreak in Italy	22
Dermatological effects of Curcuma species: a systematic review	22
Tofacitinib for the treatment of refractory pyoderma gangrenosum	22
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic	22
Comorbidities of alopecia areata: a population‐based cohort study	21
Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period	20
Cutaneous manifestations in COVID‐19: familial cluster of urticarial rash	20
Recognizable vascular skin manifestations of SARS‐CoV‐2 (COVID‐19) infection are uncommon in patients with darker skin phototypes	20
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis	19
Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review	19
Sex‐ and gender‐associated clinical and psychosocial characteristics of patients with psoriasis	19
TikTok™ and dermatology: promises and pearls	19
COVID‐19‐associated herpetic gingivostomatitis	19
Novel outbreak of acral lesions in times of COVID‐19: a description of 74 cases from a tertiary university hospital in Spain	19
Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo	18
Capillary malformation−arteriovenous malformation syndrome: a multicentre study	18
Radiation recall dermatitis triggered by inactivated COVID‐19 vaccine	18
Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot st	17
Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination	17
A clinical review and history of pubic lice	17
Successful treatment of recalcitrant nodular prurigo with tofacitinib	17
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients	16
Observations about sexual and other routes of SARS‐CoV‐2 (COVID‐19) transmission and its prevention	16
Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia	16
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity	16
Impact of COVID‐19 on Mohs micrographic surgery: UK‐wide survey and recommendations for practice	16
COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast	16
Mask‐induced dermatoses during the COVID‐19 pandemic: a questionnaire‐based study in 12 Korean hospitals	15
Scratching damages tight junctions through the Akt–claudin 1 axis in atopic dermatitis	15
Interleukin‐9 serves as a key link between systemic inflammation and angiogenesis in psoriasis	15
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID‐19 vaccine	15
Primary cutaneous anaplastic large‐cell lymphoma: a review of the SEER database from 2005 to 2016	15

Learning new ways of teaching and assessment: the impact of COVID‐19 on undergraduate dermatology education	15
ChatGPT-3.5 and ChatGPT-4 dermatological knowledge level based on the Specialty Certificate Examination in Dermatology	15
Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination	15
Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series	15
COVID‐19‐induced toxic epidermal necrolysis	15
Comment on ‘Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital’. Pseudoherpetic Grover disease seems to occur in patients with COV	15
TikTok™ and dermatology: lessons for medical education	15
Environmentally sustainable dermatology	14
Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination	14
De novo subacute cutaneous lupus erythematosus‐like eruptions in the setting of programmed death‐1 or programmed death ligand‐1 inhibitor therapy: clinicopathological correlation	14
Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab	14
Ribonucleic acid COVID‐19 vaccine‐associated cutaneous adverse drug events: a case series of two patients	14
Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis	14
Surgical plume in dermatology: an insidious and often overlooked hazard	14
MABp1 targeting interleukin‐1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open‐label extension period	13
Severe cutaneous adverse reaction following COVID‐19 vaccination and immunotherapy: a second hit?	13
The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis	13
The fate of major dermatology conferences and meetings of 2020: are e‐conferences and digital learning the future?	13
Perceptions of the use of artificial intelligence in the diagnosis of skin cancer: an outpatient survey	13
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study	13
Childhood rosacea and related disorders	13
Porocarcinoma: a review	13
A targeted response to the COVID‐19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals	13
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation	12
Allergic and cutaneous reactions following inactivated SARS‐CoV‐2 vaccine (CoronaVac ® ) in healthcare workers	12
Hydroquinone: myths and reality	12
Remote consultations for patients with hidradenitis suppurativa during the COVID‐19 pandemic: a single‐centre experience	12
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role?	12
Successful use of tofacitinib in epidermolysis bullosa pruriginosa	12
Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant	12
Clascoterone as a novel treatment for androgenetic alopecia	11
Treatment of pemphigoid gestationis with dupilumab	11
Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma	11
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results	11
Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology	11
Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis	11
Evaluation of the Dermatological Life Quality Index, sexual dysfunction and other psychiatric diseases in patients diagnosed with vitiligo with and without genital involvement	11
Acne treatments: future trajectories	11
Ketoconazole 2% cream alters the skin fungal microbiome in seborrhoeic dermatitis: a cohort study	11
Analysis of the first 5 years of an interdisciplinary Rheumatology–Dermatology clinic	11
Structural and functional differences in skin of colour	11
Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug‐resistance testing in leprosy?	11
Differential diagnosis and management of hyperpigmentation	11
#corticophobia: a review on online misinformation related to topical steroids	11
Quality of life and sexuality in women with lichen sclerosus: a cross‐sectional study	10
Successful treatment of dermatomyositis and associated calcinosis with adalimumab	10
A Piez-o the jigsaw: the Piezo1 channel in skin biology	10
Long‐term antibiotic use for the treatment of hidradenitis suppurativa consistent with guideline recommendations	10
Ultraviolet radiation‐induced degradation of dermal extracellular matrix and protection by green tea catechins: a randomized controlled trial	10
A UK‐wide survey looking at teaching and trainee confidence in teledermatology: a vital gap in a COVID‐19‐induced era of rapid digital transformation?	10
Successful treatment of trichothiodystrophy with dupilumab	10
Unleashing carbon emissions savings with regular teledermatology clinics	10
Shaping the future of teledermatology: a literature review of patient and provider satisfaction with synchronous teledermatology during the COVID-19 pandemic	10
A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis	10
Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in central London	10
Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa	10
Dermoscopic features and screening strategies for the detection of small‐diameter melanomas	10
Comparison of transepidermal water loss and skin hydration in diabetics and nondiabetics	10
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib	10
Drug‐induced alopecia areata?	10
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab	9
Mental health and dermatology practice in the COVID‐19 pandemic	9
Classification of aplasia cutis congenita: a 25‐year review of cases presenting to a tertiary paediatric dermatology department	9
Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience	9
Apremilast in benign chronic pemphigus (Hailey–Hailey disease)	9
Paradoxical eczema in patients with psoriasis receiving biologics: a case series	9
Usefulness of high‐frequency ultrasonography in the evaluation and monitoring of sclerosing dermatoses: a cohort study	9
Reporting regression in primary cutaneous melanoma. Part 1: history, histological criteria and pathogenesis	9
Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris	9
Pyridoxine for prevention of hand–foot syndrome caused by chemotherapy agents: a meta‐analysis	9
Severe atopic dermatitis treated successfully with dupilumab throughout pregnancy	9
Psoriasis and osteoporosis: a literature review	9
Teledermoscopy as a community based diagnostic test in the era of COVID‐19?	9
Assessment of inter‐rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography	9
Comment on ‘ De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine’: possible role for Type I interferons	9
Reporting regression in primary cutaneous melanoma. Part 2: prognosis, evaluation and management	9
Spironolactone in dermatology: uses in acne and beyond	9
Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa	9
Effects of systemic therapies on pruritus in adults with atopic dermatitis: a systematic review and meta-analysis	9
Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindication for revaccination	9

Panton–Valentine leucocidin-producing Staphylococcus aureus: a clinical review	8
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-int	8
Comment on ‘Two cases of COVID‐19 presenting with a clinical picture resembling chilblains: first report from the Middle East’: pernio unrelated to COVID‐19	8
Skin lightening: causes and complications	8
Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in norma	8
Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population	8
Delayed localized hypersensitivity reactions to COVID‐19 mRNA vaccines: a 6‐month retrospective study	8
Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France	8
Monkeypox: key pointers for dermatologists	8
Potentiating cutaneous wound healing in young and aged skin with nutraceutical collagen peptides	8
Scratching the surface: a review of online misinformation and conspiracy theories in atopic dermatitis	8
Male genital lichen sclerosus associated with urological interventions and microincontinence: a case series of 21 patients	8
Co‐occurrence of Aicardi–Goutières syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1 : a case series fr	8
The impact of COVID‐19 on dermatology outpatient services in England in 2020	8
Ocular and auditory abnormalities in patients with vitiligo: a case–control study	8
An analysis of qualitative responses from a UK survey of the psychosocial wellbeing of people with skin conditions and their experiences of accessing psychological support	8
Psychosocial burden and out‐of‐pocket costs in patients with atopic dermatitis in Ireland	8
Chronic urticaria in the real‐life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study	8
Slack as a virtual undergraduate dermatology community: a pilot study	8
Topical steroid withdrawal through the lens of social media	8
Erythema annulare centrifugum induced by COVID‐19 vaccination	8
Favipiravir‐induced cutaneous adverse reactions in patients infected with COVID‐19	8
Probiotics in hidradenitis suppurativa: a potential treatment option?	8
Palmar digital vein thrombosis in a patient with COVID‐19	8
In vitro survival of scabies mites	8
Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data	8
Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study	8
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib	8
News on infantile haemangioma. Part 1: clinical course and pathomechanism	8
COVID‐19: challenges and solutions for the future of UK dermatology undergraduate curriculum delivery	8
Clinical phenotypes and therapeutic responses in cutaneous‐predominant sarcoidosis: 6‐year experience in a tertiary referral service	8
Combination dermoscopy highlights fungal invasion of vellus hair in tinea vellus	8
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice	8
Topical timolol in dermatology: infantile haemangiomas and beyond	8
Genes and phenotypes in vascular malformations	7
A novel c.671_682del NCSTN variant in a family with hidradenitis suppurativa: a pilot study	7
Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation	7
Improvement of Hailey–Hailey disease with abrocitinib	7
Association of prurigo nodularis and infectious disease hospitalizations: a national cross‐sectional study	7
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross‐sectional, multicentre study of 263 patients	7
Anakinra for recalcitrant pyoderma gangrenosum	7
Comment on ‘Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?’: Type I interferons as possible link between COVID‐19 vaccine and vitiligo	7
Shades of grey: what is paediatric psoriasiform dermatitis and what does it have in common with childhood psoriasis?	7
Clinical presentation, sonographic features and treatment options of segmental stiff skin syndrome	7
Prevalence of hidradenitis suppurativa in Malta: comparison with established epidemiological data	7
Fast‐tracking teledermatology into dermatology trainee timetables, an overdue necessity in the COVID era and beyond	7
Interleukin-17A immune pattern across genetic acantholytic and blistering disorders	7
Vogt–Koyanagi–Harada‐like syndrome in the setting of combined anti‐PD1/anti‐CTLA4 therapy	7
The association of psoriasis and hypertension: focusing on anti‐inflammatory therapies and immunological mechanisms	7
The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?	7
Menopause, skin and common dermatoses. Part 1: hair disorders	7
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow‐up	7
A novice's guide to qualitative health professions education research	7
Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study	7
Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologics	7
Male genital lichen sclerosus, microincontinence and occlusion: mapping the disease across the prepuce	7
A paradigm shift in trainee confidence in teledermatology and virtual working during the COVID‐19 pandemic: results of a follow‐up UK‐wide survey	7
Inpatient teledermatology improves diagnostic accuracy and management of erythroderma in hospitalized patients	7
Evaluation of serum cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide levels in patients with alopecia areata	7
Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review	7
The human microbiome in immunobullous disorders and lichen planus	7
Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker	7
Patient perceptions of Mohs micrographic surgery during the COVID‐19 pandemic and lessons for the next outbreak	7
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group	7
Every cloud has a silver lining: the environmental benefit of teledermatology during the COVID‐19 pandemic	7
Dermatological surgery: an update on suture materials and techniques. Part 1	7
Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis	6
High‐dose bilastine for the treatment of BASCULE syndrome	6
Secure communication conduits during COVID‐19 lockdown	6
Super‐high magnification dermoscopy can aid the differential diagnosis between melanoma and atypical naevi	6
Taipan snake venom time for antiphospholipid syndrome solves a 20‐year diagnostic challenge	6
UK psychodermatology services in 2019: service provision has improved but is still very poor nationally	6
Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea	6
The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL‐1 cell growth	6
Laser therapy is a safe and effective treatment for unwanted hair in adults undergoing male to female sex reassignment	6
Isotretinoin on TikTok™: misinformation getting under our skin	6
Socioeconomic status and skin cancer incidence: a population‐based, cohort study in the province of Ferrara, northern Italy	6
Clinical and histopathological features of adult patients with dermatomyositis and melanoma differentiation associated‐5 autoantibody seropositivity status, as determined by commercially available tes	6
Exploring the implications of the first COVID‐19 lockdown on patients with melanoma: a national survey	6
Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab	6
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository	6
Comparison of the clinical efficacy of subcutaneous vs. oral administration of methotrexate in patients with psoriasis vulgaris: a randomized controlled trial	6
The British Association of Dermatologists’ Undergraduate Curriculum Update 2021	6
Dupilumab unmasking cutaneous T‐cell lymphoma: report of a fatal case	6
Adherence to treatment with prescribed topical corticosteroid therapy and potential barriers to adherence among women with vulvar lichen sclerosus: a prospective cross‐sectional study	6
Dermatological insights from Google Trends: what does the public think is important during COVID‐19 lockdown?	6
Misdiagnosed scabies correctly diagnosed by dermoscopy using ultraviolet light mode	6
Direct immunofluorescence findings in livedoid vasculopathy: a 10‐year study and literature review	6
Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain	6
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies	6
Morphoea following COVID-19 vaccination	6
Aquagenic wrinkling of the palms: review of the literature	6
A review of Mohs micrographic surgery for skin cancer. Part 1: Melanoma and rare skin cancers	6
	6
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end‐products	6